GO Term | Evidence Code | PMID |
---|---|---|
MHC class II biosynthetic process | ||
cellular response to mechanical stimulus |
|
|
ERK1 and ERK2 cascade | ||
activation of innate immune response | ||
nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO Term | Evidence Code | PMID |
---|---|---|
receptor complex | ||
endosome | ||
cytoplasm | ||
external side of plasma membrane | ||
lipopolysaccharide receptor complex |
GO Term | Evidence Code | PMID |
---|---|---|
transmembrane signaling receptor activity | ||
phosphatidylinositol 3-kinase binding | ||
NAD+ nucleotidase, cyclic ADP-ribose generating |
|
|
signaling receptor binding | ||
lipopolysaccharide binding |
DO ID | Disease Name | Source |
---|---|---|
DOID:869 | cholesteatoma | |
DOID:8893 | psoriasis | |
DOID:8947 | diabetic retinopathy | |
DOID:9111 | cutaneous leishmaniasis | |
DOID:9351 | diabetes mellitus | |
DOID:9352 | type 2 diabetes mellitus | |
DOID:9675 | pulmonary emphysema | |
DOID:9743 | diabetic neuropathy | |
DOID:9744 | type 1 diabetes mellitus | |
DOID:9970 | obesity |
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
116835169 | CHEAB00370 | ||
105292652 | PTEVA16879 | ||
105826455 | PROCO08913 | ||
109066035 | CYPCA66515 | ||
109066037 | CYPCA66514 | ||
109100795 | CYPCA79514 | ||
109100796 | CYPCA79514 | ||
103734505 | NANGA02165 | ||
116454430 | CORMO10721 | ||
103255573 | CARSF26626 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024